There is a need for a simple method of expressing nuchal translucency
measurement in early pregnancy that will allow for gestational age and
be useful in screening for Down's syndrome. To achieve this objective
, we conducted a prospective study of 561 women with singleton pregnan
cies that were not affected by Down's syndrome at 10-13 weeks of gesta
tion. Nuchal translucency measurements and crown rump length measureme
nts were determined. Nuchal translucency measurement increased by abou
t 17 per cent per week. Expressing the result as a multiple of the med
ian (MOM) nuchal translucency for a given crown rump length allowed fo
r this increase with gestational age and yielded a distribution of val
ues that was approximately Gaussian. About 96 per cent of values lay b
etween 0.5 and 2.0 MOM. The variance and therefore the false-positive
rate of nuchal translucency were significantly reduced by recording se
veral measurements and using the average: for example, the false-posit
ive rate reduced from 8.3 per cent to 5.0 per cent if the average of s
ix measurements were used instead of one-a potential 40 per cent reduc
tion in the false-positive rate if the test were used in screening. Es
timating the distribution of nuchal translucency in MOM values will as
sist in specifying the statistical parameters to be used in prenatal s
creening for Down's syndrome and the use of repeated nuchal translucen
cy measurements is expected to have a useful effect on reducing the sc
reening false-positive rate at a given MOM cut-off level. (C) 1998 Joh
n Wiley & Sons, Ltd.